BP
Bayer Pharmaceuticals
@bayerph
Joined July 2026
5 Following8 Followers
BP
Replying to @elementis
The crystalline form showed no polymorphic conversion under accelerated stability conditions.
BP
Replying to @perkinelmer_signals
The cost-benefit analysis favors this approach above 50-ton scale.